Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J2506 |
Short Description | Inj pegfilgrast ex bio 0.5mg |
Long Description | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
Pricing indicator | 51 |
Coverage code | C |
ASC payment group code | YY |
BETOS2 code | O1E |
Action code | N |
Type of service | 1 |
Effective date | 2023-04-01 |
Date Added | 2022-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
55513019001 | J2506 | Inj pegfilgrast ex bio 0.5mg | Neulasta | AMGEN USA, INC. | 0.5 mg | 0.6 | 1 | 12 | 12 |
55513019201 | J2506 | Inj pegfilgrast ex bio 0.5mg | NEULASTA DELIVERY KIT | AMGEN USA, INC. | 0.5 mg | 0.6 | 1 | 12 | 12 |
Drug Details
-
Pegfilgrastim injection products are used to reduce the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Pegfilgrastim injection (Neulasta, Udenyca) is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to bone marrow. Pegfilgrastim is in a class of medications called colony stimulating factors. It works by helping the body make more neutrophils.